Loading clinical trials...
Loading clinical trials...
Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Conditions
Interventions
Moderate Dose Hydroxyurea
Low Dose Hydroxyurea
Locations
2
Nigeria
Aminu Kano Teaching Hospital
Kano, Nigeria
Murtala Muhammad Specialist Hospital
Kano, Nigeria
Start Date
January 1, 2017
Primary Completion Date
March 31, 2020
Completion Date
March 31, 2020
Last Updated
January 19, 2022
NCT07371455
NCT06258538
NCT05093673
NCT07253181
NCT06870812
NCT05147792
Lead Sponsor
Vanderbilt University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions